At a Glance
- Lenacapavir, a twice-yearly injection to prevent or treat HIV infection, could be mass produced for as low as $25 per patient per year, according to a new study.
- A generic version of lenacapavir could cost $35-$46 per patient per year…
HIV preventive treatment could be sold for one thousandth of current list price
